ω-3 Polyunsaturated fatty acid biomarkers and coronary heart disease: Pooling project of 19 cohort studies

JAMA Internal Medicine

Volumn 176, Issue 8, 2016, Pages 1155-1166

  Del Gobbo, Liana C ^a   Imamura, Fumiaki ^b   Aslibekyan, Stella ^c   Marklund, Matti ^d   Virtanen, Jyrki K ^e   Wennberg, Maria ^f   Yakoob, Mohammad Y ^a   Chiuve, Stephanie E ^g,h   Dela Cruz, Luicito ⁱ   Frazier Wood, Alexis C ^j   Fretts, Amanda M ^k   Guallar, Eliseo ^l   Matsumoto, Chisa ^g,m   Prem, Kiesha ⁿ   Tanaka, Tosh ^o   Wu, Jason H Y ^p   Zhou, Xia ^q   Helmer, Catherine ^r,s   Ingelsson, Erik ^a,t   Yuan, Jian Min ^u,v   Barberger Gateau, Pascale ^r,s   Campos, Hannia ^h   Chaves, Paulo H M ^w   Djoussé, Luc ^g   Giles, Graham G ⁱ   Gómez Aracena, Jose ^x   Hodge, Allison M ⁱ   Hu, Frank B ^h,y   Jansson, Jan Håkan ^f   Johansson, Ingegerd ^f   Khaw, Kay Tee ^z   Koh, Woon Puay ^n,aa   Lemaitre, Rozenn N ^ab   Lind, Lars ^t   Luben, Robert N ^z   Rimm, Eric B ^h,y   Risérus, Ulf ^d   Samieri, Cecilia ^r,s   Franks, Paul W ^f,h,ac   Siscovick, David S ^ad   Stampfer, Meir ^h,y   Steffen, Lyn M ^q   Steffen, Brian T ^q   Tsai, Michael Y ^ae   Van Dam, Rob M ^h,n,af   Voutilainen, Sari ^e   Willett, Walter C ^h,y   Woodward, Mark ^l,p,ag   Mozaffarian, Dariush ^ah   more..

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UPPSALA UNIVERSITY   (Sweden)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f UMEÅ UNIVERSITY   (Sweden)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ CANCER EPIDEMIOLOGY CENTRE   (Australia)

^j BAYLOR COLLEGE OF MEDICINE   (United States)

^k UNIVERSITY OF WASHINGTON   (United States)

^l JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^m TOKYO MEDICAL UNIVERSITY   (Japan)

ⁿ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^o NATIONAL INSTITUTE ON AGING   (United States)

^p UNIVERSITY OF SYDNEY   (Australia)

^q UNIVERSITY OF MINNESOTA   (United States)

^r INSERM   (France)

^s UNIVERSITÉ DE BORDEAUX   (France)

^t UPPSALA UNIVERSITY   (Sweden)

^u UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^v UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^w FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^x UNIVERSITY OF MÁLAGA   (Spain)

^y HARVARD MEDICAL SCHOOL   (United States)

^z UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^aa DUKE NUS MEDICAL SCHOOL   (Singapore)

^ab UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^ac LUND UNIVERSITY   (Sweden)

^ad NEW YORK ACADEMY OF MEDICINE   (United States)

^ae UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^af Dept Medicine Endocrinol Diabet   (Singapore)

^ag UNIVERSITY OF OXFORD   (United Kingdom)

^ah TUFTS UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; CHOLESTEROL ESTER; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; LINOLENIC ACID; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID; TRIACYLGLYCEROL; UNSATURATED FATTY ACID;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; ERYTHROCYTE; FATTY ACID BLOOD LEVEL; FEMALE; HEART INFARCTION; HUMAN; INCIDENTAL FINDING; ISCHEMIC HEART DISEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOSPHOLIPID BLOOD LEVEL; PRIMARY PREVENTION; PRIORITY JOURNAL; SEA FOOD; TISSUE LEVEL; BLOOD; CORONARY DISEASE; INCIDENCE; ODDS RATIO;

ALPHA-LINOLENIC ACID; BIOMARKERS; COHORT STUDIES; CORONARY DISEASE; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; INCIDENCE; MALE; ODDS RATIO;

EID: 84980320220     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2016.2925     Document Type: Article

References (58)

1. Mozaffarian D, Wu JHY. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J AmColl Cardiol. 2011;58(20):2047-2067.
2. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: ameta-analysis of randomized controlled trials. Am J Med. 2002;112(4):298-304.
3. Hooper L, Thompson RL, Harrison RA, et al. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev. 2004;(4): CD003177.
4. León H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki RT. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ. 2008;337:a2931. doi:10.1136/bmj.a2931.
5. Marik PE, Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol. 2009;32(7):365-372.
6. Trikalinos TA, Lee J, Moorthy D, et al. Effects of Eicosapentanoic Acid and Docosahexanoic Acid on Mortality Across Diverse Settings: Systematic Review and Meta-analysis of Randomized Trials and Prospective Cohorts. Rockville, MD: Agency for Healthcare Research and Quality; 2012.
7. Kwak SM, Myung SK, Lee YJ, Seo HG; Korean Meta-analysis Study Group. Efficacy of ω-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: ameta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med. 2012;172(9):686-694.
8. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between ω-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012;308(10):1024-1033.
9. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296(15): 1885-1899.
10. Mozaffarian D, Wu JH. (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? J Nutr. 2012;142(3): 614S-625S.
11. Pan A, Chen M, Chowdhury R, et al. α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr. 2012;96 (6):1262-1273.
12. Psaty BM, O'Donnell CJ, Gudnason V, et al; CHARGE Consortium. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: design of prospectivemeta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009;2(1):73-80.
13. Lemaitre RN, Tanaka T, Tang W, et al. Genetic loci associated with plasma phospholipid n-3 fatty acids: ameta-analysis of genome-wide association studies from the CHARGE Consortium. PLoS Genet. 2011;7(7):e1002193. doi:10.1371/journal.pgen.1002193.
14. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health. 1951;41(3):279-281.
15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
16. Baylin A, Kim MK, Donovan-Palmer A, et al. Fasting whole blood as a biomarker of essential fatty acid intake in epidemiologic studies: comparison with adipose tissue and plasma. Am J Epidemiol. 2005;162(4):373-381.
17. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301-1309.
18. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129(4):687-702.
19. Campos H, Bailey SM, Gussak LS, Siles X, Ordovas JM, Schaefer EJ. Relations of body habitus, fitness level, and cardiovascular risk factors including lipoproteins and apolipoproteins in a rural and urban Costa Rican population. Arterioscler Thromb. 1991;11(4):1077-1088.
20. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1(3):263-276.
21. Day N, Oakes S, Luben R, et al. EPIC-Norfolk: study design and characteristics of the cohort: European Prospective Investigation of Cancer. Br J Cancer. 1999;80(1)(suppl 1):95-103.
22. Kardinaal AF, van 't Veer P, Kokl FJ, et al. EURAMIC Study: antioxidants, myocardial infarction and breast cancer: design and main hypotheses. Eur J Clin Nutr. 1993;47(2)(suppl 2): S64-S72.
23. Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991;338 (8765):464-468.
24. Bartali B, Benvenuti E, Corsi AM, et al. Changes in anthropometric measures in men and women across the life-span: findings from the InCHIANTI study. Soz Praventivmed. 2002;47(5):336-348.
25. Vanharanta M, Voutilainen S, Lakka TA, van der Lee M, Adlercreutz H, Salonen JT. Reduced risk of acute coronary events at high levels of mammalian lignan, enterolactone: a prospective population-based cohort study. Lancet. 1999;354: 2112-2115.
26. Giles GG, English DR. The Melbourne Collaborative Cohort Study. IARC Sci Publ. 2002; 156:69-70.
27. Bild DE, Bluemke DA, Burke GL, et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002;156(9):871-881.
28. Norberg M, Wall S, Boman K, Weinehall L. The Västerbotten Intervention Programme: background, design and implications. Global Health Action website 2010. http://www.globalhealthaction.net/index.php/gha/article/view/4643/5514. Accessed May 30, 2016.
29. Löwel H, Döring A, Schneider A, Heier M, Thorand B, Meisinger C; MONICA/KORA Study Group. The MONICA Augsburg surveys-basis for prospective cohort studies. Gesundheitswesen. 2005;67(1)(suppl 1):S13-S18.
30. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE. Dietary fat and the risk of breast cancer. N Engl J Med. 1987;316 (1):22-28.
31. Christen WG, Gaziano JM, Hennekens CH. Design of Physicians' Health Study II-a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol. 2000; 10(2):125-134.
32. Tunstall-Pedoe H, Woodward M, Tavendale R, A'Brook R, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ. 1997;315(7110):722-729.
33. Hankin JH, Stram DO, Arakawa K, et al. Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire. Nutr Cancer. 2001;39(2): 187-195.
34. 3C Study Group. Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology. 2003;22(6):316-325.
35. Hedstrand H. Results and observations from the Uppsala project [in Swedish]. Lakartidningen. 1972;69(41):4653.
36. Serhan CN. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol. 2010;177(4):1576-1591.
37. Arnold C, Konkel A, Fischer R, Schunck WH. Cytochrome P450-dependent metabolism of ω-6 and ω-3 long-chain polyunsaturated fatty acids. Pharmacol Rep. 2010;62(3):536-547.
38. Siscovick DS, Lemaitre RN, Mozaffarian D. The fish story: a diet-heart hypothesis with clinical implications: n-3 polyunsaturated fatty acids, myocardial vulnerability, and sudden death. Circulation. 2003;107(21):2632-2634.
39. Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995;274 (17):1363-1367.
40. Zheng J, Huang T, Yu Y, Hu X, Yang B, Li D. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutr. 2012;15(4):725-737.
41. Mozaffarian D, Lemaitre RN, King IB, et al. Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: the Cardiovascular Health Study. Ann Intern Med. 2013;158(7):515-525.
42. Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160(6): 398-406.
43. Holy EW, Forestier M, Richter EK, et al. Dietary α-linolenic acid inhibits arterial thrombus formation, tissue factor expression, and platelet activation. Arterioscler Thromb Vasc Biol. 2011;31(8): 1772-1780.
44. Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A. Dietary α-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis. 2003;167(2):237-242.
45. McLennan PL, Dallimore JA. Dietary canola oil modifies myocardial fatty acids and inhibits cardiac arrhythmias in rats. J Nutr. 1995;125(4):1003-1009.
46. Billman GE, Kang JX, Leaf A. Prevention of sudden cardiac death by dietary pure ω-3 polyunsaturated fatty acids in dogs. Circulation. 1999;99(18):2452-2457.
47. Thies F, Miles EA, Nebe-von-Caron G, et al. Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids. 2001;36(11):1183-1193.
48. Pauly D, Christensen V, Guénette S, et al. Towards sustainability in world fisheries. Nature. 2002;418(6898):689-695.
49. Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV. Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care. 2011;34(8): 1741-1748.
50. Wildman RP, Gu D, Reynolds K, Duan X, He J. Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults. Am J Clin Nutr. 2004;80(5):1129-1136.
51. Zheng JS, Huang T, Yang J, Fu YQ, Li D. Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis. PLoS One. 2012;7(9):e44525. doi:10.1371/journal.pone.0044525.
52. Wallin A, Di Giuseppe D, Orsini N, Patel PS, Forouhi NG, Wolk A. Fish consumption, dietary long-chain n-3 fatty acids, and risk of type 2 diabetes: systematic review and meta-analysis of prospective studies. Diabetes Care. 2012;35(4): 918-929.
53. Wu JHY, Micha R, Imamura F, et al. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr. 2012;107(suppl 2):S214-S227.
54. Wu JHY, Mozaffarian D. ω-3 Fatty acids, atherosclerosis progression and cardiovascular outcomes in recent trials: new pieces in a complex puzzle. Heart. 2014;100(7):530-533.
55. Harris WS, Mozaffarian D, Rimm E, et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation. 2009;119(6):902-907.
56. Dayton S, Hashimoto S, Dixon W, Pearce ML. Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. J Lipid Res. 1966;7(1):103-111.
57. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006;83(6) (suppl):1467S-1476S.
58. Conquer JA, Holub BJ. Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. J Lipid Res. 1998;39(2):286-292.